TY  - GEN
AU  - Leyland-Jones,Brian
AU  - Semiglazov,Vladimir
AU  - Pawlicki,Marek
AU  - Pienkowski,Tadeusz
AU  - Tjulandin,Sergei
AU  - Manikhas,George
AU  - Makhson,Antoly
AU  - Roth,Anton
AU  - Dodwell,David
AU  - Baselga,Jose
AU  - Biakhov,Mikhail
AU  - Valuckas,Konstantinas
AU  - Voznyi,Edouard
AU  - Liu,Xiangyang
AU  - Vercammen,Els
TI  - Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study
SN  - 0732-183X
PY  - 2005///0920
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Anemia
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Epoetin Alfa
KW  - Erythropoietin
KW  - adverse effects
KW  - Female
KW  - Hematinics
KW  - Hemoglobins
KW  - analysis
KW  - Humans
KW  - Injections, Subcutaneous
KW  - Middle Aged
KW  - Neoplasm Metastasis
KW  - Placebos
KW  - Quality of Life
KW  - Recombinant Proteins
KW  - Survival Analysis
N1  - Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.2005.06.150
ER  -